During the last session, Precigen Inc (NASDAQ:PGEN)’s traded shares were 1.31 million, with the beta value of the company hitting 1.64. At the end of the trading day, the stock’s price was $1.87, reflecting an intraday loss of -3.11% or -$0.06. The 52-week high for the PGEN share is $2.17, that puts it down -16.04 from that peak though still a striking 65.24% gain since the share price plummeted to a 52-week low of $0.65. The company’s market capitalization is $547.67M, and the average trade volume was 2.08 million shares over the past three months.
Precigen Inc (PGEN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. PGEN has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.05.
Precigen Inc (NASDAQ:PGEN) trade information
Precigen Inc (PGEN) registered a -3.11% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -3.11% in intraday trading to $1.87, hitting a weekly high. The stock’s 5-day price performance is 6.86%, and it has moved by 40.60% in 30 days. Based on these gigs, the overall price performance for the year is 14.72%.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 68.83% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, PGEN is trading at a discount of -220.86% off the target high and -220.86% off the low.
Precigen Inc (PGEN) estimates and forecasts
In the rating firms’ projections, revenue will decrease -8.36% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 3M as predicted by 5 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 733.33k by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 1.23M and 1.06M respectively. In this case, analysts expect current quarter sales to grow by 144.30% and then drop by -31.14% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 36.94%. While earnings are projected to return -14.53% in 2025.
PGEN Dividends
Precigen Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 10.25 million shares, is of BLACKROCK INC.’s that is approximately 4.1116% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $16.19 million.
Also, the Mutual Funds coming in first place with the largest holdings of Precigen Inc (PGEN) shares are Trust for Advised Port-Patient Opportunity Trust and Vanguard Total Stock Market Index Fund . Data provided on Dec 31, 2024 indicates that Trust for Advised Port-Patient Opportunity Trust owns about 14.4 shares. This amounts to just over 4.92 percent of the company’s overall shares, with a $26.93 million market value. The same data shows that the other fund manager holds slightly less at 5.45, or about 1.86% of the stock, which is worth about $10.2 million.
